Hydroxyapatite Crystal Deposition Disease (HADD)
Nov 15, 2022 · Hydroxyapatite deposition disease (HADD) is a condition where hydroxyapatite crystals accumulate in the soft tissues surrounding joints, leading to inflammation, tenderness, and pain. It primarily affects women around the age of 45 and commonly affects the glenohumeral joint in the shoulder. Other joints such as the hip, knee, elbow, wrist, and ...
2022 ACR/AAHKS Guidelines for Management of
Apr 6, 2022 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty: guideline summary.
Degenerative Disc Disease - Rheumatology Advisor
Aug 4, 2022 · Degenerative disc disease (DDD), as the name suggests, features disc degeneration. DDD is commonly associated with low back pain. Cervical degenerative disc disease, on the other hand, is more often the cause of neck and radiating arm pain. Degeneration of intervertebral disc tissue starts sooner than degeneration of other muscular and skeletal ...
Is Drinking Too Much Milk Bad for Your Health? - Rheumatology …
May 15, 2019 · Over the 20 years during which the women were tracked, 17,252 (28%) had sustained a fracture and 15,541 (25%) died. Women who consumed at least 3 glasses of milk per day had a higher risk of fracture and mortality compared with women who drank less than 1 glass per day. Over the 11 years during which the men were followed, 5066 (11%) had ...
Rheumatoid Arthritis Injection Treatment Approved by FDA
June 5, 2017. Regeneron Pharmaceuticals, Inc., and Sanofi announced that the US Food and Drug Administration (FDA) has approved Kevzara (sarilumab) injection to treat adults with moderate to severe rheumatoid arthritis (RA). This treatment is recommended in patients with RA who have had an inadequate response or demonstrated intolerance to one ...
Choosing the Right TNF Inhibitor Therapy for Rheumatoid Arthritis
December 20, 2017. Biologics, approved nearly 20 years ago for the treatment of rheumatoid arthritis (RA), transformed treatment, and tumor necrosis factor inhibitors (TNFis) are now usually the first and most frequently used biologics. 1. Although all TNFis block TNFα and are broadly similar in efficacy and toxicity, resulting in little ...
Musculoskeletal Pain Symptoms Common in Menopause
Jul 14, 2023 · Globally, painful musculoskeletal conditions, such as low back pain and neck pain, are collectively the sixth-ranked cause of years lived with disability. 1 Many of these conditions tend to be more common among adult women of more advanced age. In a review published in Lancet Rheumatology in April 2023, researchers examined the association between changes in sex hormones with musculoskeletal ...
What Is the Role of Immunoglobulins in Patients With Systemic …
Jul 9, 2021 · Low immunoglobulin levels are not rare among patients with systemic lupus erythematosus (SLE) and may signal an increased risk for bacterial infection. 1 . In a narrative review published in Lupus, authors discussed immunoglobulin (Ig) measurements and primary and secondary causes of hypogammaglobulinemia in patients with SLE. 1. Lupus is a chronic autoimmune disease of unknown etiology that ...
Significant benefit seen with obinutuzumab in lupus nephritis trial
October 1, 2024. The trial met its primary endpoint showing a significant improvement in complete renal response with obinutuzumab with standard therapy vs standard therapy alone after 76 weeks. Positive topline results were announced from a phase 3 study of obinutuzumab in patients with lupus nephritis. Obinutuzumab, a monoclonal antibody that ...
Rheumatology Advisor
Rheumtaology Advisor offers featured news, research updates, and treatment guidelines to Rheumatology healthcare professionals.